Latest Strategy Changes News

Miramar Resources has partnered with Topdrill in a drill-for-equity agreement to fund significant drilling at the promising 8 Mile gold target within its Gidji JV Project near Kalgoorlie. Drilling is set to begin in July, aiming to explore extensions of a known gold deposit.

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.

NexGen Energy has secured regulatory approval for a significant infrastructure upgrade at its Rook I uranium project, setting the stage for expanded exploration and operational efficiency in 2025.

FireFly Metals Ltd has announced a flow-through share offer aiming to raise approximately A$11.2 million, targeting Canadian investors to fund regional exploration drilling. This offer complements a broader capital raising strategy to advance development at the Ming Mine and other key projects.

Harmoney’s founder Neil Roberts has sold 3.6 million shares, reducing his stake to 15%, as he transitions from Chief Strategy Officer to a non-executive director role.

BetMakers Technology Group has successfully raised $11.5 million through a share placement aimed at repaying debt and funding strategic growth initiatives, including a potential acquisition in Nevada.

Hazel Group Limited has temporarily paused trading of its securities on the ASX, signaling an impending announcement that investors will want to watch closely.

Aureka Limited has raised $3 million through a share placement to accelerate exploration and secure land access at its key gold projects in Victoria, signalling strong investor confidence in its growth strategy.

MPower Group has struck a deal to sell nearly all its renewable energy assets to Wollemi Energy Group for about $19 million, unlocking significant shareholder value and setting the stage for a strategic reset.

AGL Energy has confirmed it is reviewing its 20% stake in Tilt Renewables following recent media speculation, though no sale discussions are underway. The outcome remains uncertain as the company conducts preliminary assessments.

AnteoTech secures a significant purchase order from the Serum Institute of India, driving its Life Sciences unit toward a projected 130% sales increase in FY2025 despite some project delays.

Lynch Group reports robust FY25 trading results, driven by strong Australian and Chinese markets, and sets optimistic full-year revenue and earnings guidance.